NCT07060651 Characterization of Human Olfactory Amygdala Subregions Exp3
| NCT ID | NCT07060651 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Human Olfactory Amygdala Function |
| Study Type | INTERVENTIONAL |
| Enrollment | 12 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2027-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 12 participants in total. It began in 2022-01-01 with a primary completion date of 2027-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We aim to better understand the functions of the subregions of the human amygdala that receive direct projections from the olfactory bulb
Eligibility Criteria
Inclusion Criteria: * older than 18 years of age Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07060651 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Human Olfactory Amygdala Function. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07060651 currently recruiting?
Yes, NCT07060651 is actively recruiting participants. Contact the research team at c-zelano@northwestern.edu for enrollment information.
Where is the NCT07060651 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT07060651 clinical trial?
NCT07060651 is sponsored by Northwestern University. The trial plans to enroll 12 participants.